azathioprine

Generic: azathioprine

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name azathioprine
Generic Name azathioprine
Labeler avkare
Dosage Form TABLET
Routes
ORAL
Active Ingredients

azathioprine 50 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-071
Product ID 42291-071_485b4c20-1aec-8ffd-e063-6294a90a104f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074069
Listing Expiration 2027-12-31
Marketing Start 2022-01-04

Pharmacologic Class

Established (EPC)
purine antimetabolite [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]
Chemical Structure
nucleosides [cs] purines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291071
Hyphenated Format 42291-071

Supplemental Identifiers

RxCUI
197388
UNII
MRK240IY2L
NUI
N0000000233 M0015066 N0000175712 M0018169

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name azathioprine (source: ndc)
Generic Name azathioprine (source: ndc)
Application Number ANDA074069 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (42291-071-01)
source: ndc

Packages (1)

42291-071-01 100 TABLET in 1 BOTTLE (42291-071-01)

Ingredients (1)

azathioprine (50 mg/1)

Linked Drug Pages (1)

AZATHIOPRINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "485b4c20-1aec-8ffd-e063-6294a90a104f", "openfda": {"nui": ["N0000000233", "M0015066", "N0000175712", "M0018169"], "unii": ["MRK240IY2L"], "rxcui": ["197388"], "spl_set_id": ["d4c7d621-9642-4027-e053-2995a90a9220"], "pharm_class_cs": ["Nucleosides [CS]", "Purines [CS]"], "pharm_class_epc": ["Purine Antimetabolite [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-071-01)", "package_ndc": "42291-071-01", "marketing_start_date": "20220104"}], "brand_name": "AZATHIOPRINE", "product_id": "42291-071_485b4c20-1aec-8ffd-e063-6294a90a104f", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleosides [CS]", "Purine Antimetabolite [EPC]", "Purines [CS]"], "product_ndc": "42291-071", "generic_name": "Azathioprine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZATHIOPRINE", "active_ingredients": [{"name": "AZATHIOPRINE", "strength": "50 mg/1"}], "application_number": "ANDA074069", "marketing_category": "ANDA", "marketing_start_date": "20220104", "listing_expiration_date": "20271231"}